Evolent Health, Inc.
EVHNYSECIK 1628908IndustrialsFiscal year ends Dec 31
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0608:53 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628908-26-000086 |
| 2026-08-0607:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-26-000084 |
| 2026-06-0416:05 ET | 8-K | 5.07 Shareholder vote results | 0001628908-26-000037 |
| 2026-05-0708:46 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628908-26-000033 |
| 2026-05-0707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-26-000031 |
| 2026-04-2416:13 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-177267 |
| 2026-02-2518:16 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628908-26-000015 |
| 2026-02-2416:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-26-000014 |
| 2025-12-0808:00 ET | 8-K | 8.01 Other events | 0001628908-25-000145 |
| 2025-12-0207:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001628908-25-000141 |
| 2025-11-0717:47 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628908-25-000133 |
| 2025-11-0616:21 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628908-25-000132 |
| 2025-09-2316:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-25-000124 |
| 2025-08-2117:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-185388 |
| 2025-08-1908:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-183075 |
| 2025-08-1816:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-182692 |
| 2025-08-1106:27 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628908-25-000116 |
| 2025-08-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-25-000112 |
| 2025-06-2006:32 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-25-000098 |
| 2025-06-0516:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628908-25-000072 |
| 2025-06-0306:48 ET | 8-K | 7.01 Regulation FD disclosure | 0001628908-25-000069 |
| 2025-05-0917:54 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628908-25-000066 |
| 2025-05-0816:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-25-000064 |
| 2025-04-2516:07 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0001193125-25-096749 |
| 2025-04-2206:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-25-000055 |
| 2025-02-2118:22 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628908-25-000020 |
| 2025-02-2016:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-25-000018 |
| 2025-02-0407:01 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-25-000010 |
| 2025-01-3016:20 ET | 8-K | 2.03 New direct financial obligation | 0001628908-25-000008 |
| 2025-01-1316:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-25-000004 |
| 2024-12-1116:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628908-24-000117 |
| 2024-11-0818:19 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628908-24-000114 |
| 2024-11-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000112 |
| 2024-08-0917:59 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628908-24-000090 |
| 2024-08-0816:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000089 |
| 2024-06-1116:08 ET | 8-K | 5.07 Shareholder vote results | 0001628908-24-000080 |
| 2024-06-0407:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-24-000057 |
| 2024-05-1018:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628908-24-000053 |
| 2024-05-0916:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000051 |
| 2024-04-2616:20 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001193125-24-118116 |
| 2024-02-2318:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628908-24-000017 |
| 2024-02-2216:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628908-24-000015 |
| 2024-02-1416:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-24-000010 |
| 2024-01-0817:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628908-24-000005 |
| 2023-12-1118:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000192 |
| 2023-12-0606:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000183 |
| 2023-12-0507:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000180 |
| 2023-11-0308:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000176 |
| 2023-11-0320:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628908-23-000169 |
| 2023-11-0217:18 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628908-23-000165 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.